نتائج البحث - "Phase 3 trials"

1

دورية أكاديمية

Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer

المؤلفون: Matthieu Delaye, Adrien Rousseau, Mélanie Try, Christophe Massard, Luca Campedel, Marc Hilmi, Corinne Bagnis

المصدر: Cancer Medicine, Vol 12, Iss 3, Pp 3172-3175 (2023)

مصطلحات موضوعية: chronic kidney disease, enrollment, onco‐nephrology, phase 3 trials, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2045-7634Test

الوصول الحر: https://doaj.org/article/307fbb4f1f4e4f7a836b0e41278a0e6dTest

View record in DOAJ

النص الكامل

2

دورية أكاديمية

Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer

المؤلفون: Delaye, Matthieu, Rousseau, Adrien, Try, Mélanie, Massard, Christophe C., Campedel, Luca, Hilmi, Marc, Bagnis, Corinne

المساهمون: Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Institut Gustave Roussy (IGR), Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CRLCC Eugène Marquis (CRLCC), UNICANCER, Université de Rennes (UR), CHU Gabriel Montpied Clermont-Ferrand, CHU Clermont-Ferrand, CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

المصدر: ISSN: 2045-7634.

مصطلحات موضوعية: chronic kidney disease, enrollment, onco-nephrology, phase 3 trials, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36156460; hal-04122347; https://hal.science/hal-04122347Test; https://hal.science/hal-04122347/documentTest; https://hal.science/hal-04122347/file/Cancer%20Medicine%20-%202022%20-%20Delaye%20-%20Inclusion%20of%20patients%20with%20chronic%20kidney%20disease%20in%20randomized%20phase%203%20clinical%20trials.pdfTest; PUBMED: 36156460

الإتاحة: https://doi.org/10.1002/cam4.5171Test
https://hal.science/hal-04122347Test
https://hal.science/hal-04122347/documentTest
https://hal.science/hal-04122347/file/Cancer%20Medicine%20-%202022%20-%20Delaye%20-%20Inclusion%20of%20patients%20with%20chronic%20kidney%20disease%20in%20randomized%20phase%203%20clinical%20trials.pdfTest

View record in BASE

3

دورية أكاديمية

Accelerating progress to innovation for patients: Trial design and risk stratification

المؤلفون: Meredith M. Regan

المصدر: Breast, Vol 62, Iss , Pp S80-S83 (2022)

مصطلحات موضوعية: Neoadjuvant therapy, Triple-negative breast cancer, Immune checkpoint inhibitors, Hormone receptor-positive breast cancer, Phase 3 trials, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S0960977621009930Test; https://doaj.org/toc/1532-3080Test

الوصول الحر: https://doaj.org/article/44a1d0dd10c94d8584e45d6a79f4eed8Test

View record in DOAJ

النص الكامل

4

دورية أكاديمية

Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trials.

المؤلفون: Silverberg, Jonathan I, Eichenfield, Lawrence F, Hebert, Adelaide A, Simpson, Eric L, Stein Gold, Linda, Bissonnette, Robert, Papp, Kim A, Browning, John, Kwong, Pearl, Korman, Neil J, Brown, Philip M, Rubenstein, David S, Piscitelli, Stephen C, Somerville, Matthew C, Tallman, Anna M, Kircik, Leon

المصدر: J Am Acad Dermatol ; ISSN:1097-6787

مصطلحات موضوعية: aryl hydrocarbon receptor agonist, atopic dermatitis, atopic eczema, randomized controlled phase 3 trials, tapinarof cream 1% QD, topical therapy

العلاقة: https://doi.org/10.1016/j.jaad.2024.05.023Test; https://pubmed.ncbi.nlm.nih.gov/38777187Test

الإتاحة: https://doi.org/10.1016/j.jaad.2024.05.023Test
https://pubmed.ncbi.nlm.nih.gov/38777187Test

View record in BASE

5

دورية أكاديمية

Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist

المؤلفون: Jian Zhao (219525), Shimiao Wang (14243617), Stacy Markison (2392726), Sun Hee Kim (228574), Sangdon Han (1706680), Mi Chen (32731), Ana Karin Kusnetzow (14243620), Elizabeth Rico-Bautista (14243623), Michael Johns (23390), Rosa Luo (14243626), R. Scott Struthers (2403748), Ajay Madan (2351155), Yunfei Zhu (9505384), Stephen F. Betz (2514379)

العلاقة: https://figshare.com/articles/journal_contribution/Discovery_of_Paltusotine_CRN00808_a_Potent_Selective_and_Orally_Bioavailable_Non-peptide_SST2_Agonist/21707071Test

الإتاحة: https://doi.org/10.1021/acsmedchemlett.2c00431.s001Test

View record in BASE

6

دورية أكاديمية

An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy

المؤلفون: Vanneste, Ben G. L., Van Limbergen, Evert J., Reynders, Kobe, De Ruysscher, Dirk

المصدر: Vanneste , B G L , Van Limbergen , E J , Reynders , K & De Ruysscher , D 2021 , ' An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy ' , Translational Lung Cancer Research , vol. 10 , no. 4 , pp. 2048-2058 . https://doi.org/10.21037/tlcr-20-304Test

مصطلحات موضوعية: Radiotherapy, immunotherapy, review, clinical phase 3 trials, radiosensitization, CELL LUNG-CANCER, DOUBLE-BLIND, PLACEBO, CONCURRENT, IPILIMUMAB